Group 1 - The core point of the article is that Beijing will launch a free HPV vaccination program for first-year female students in September 2025, targeting cervical cancer prevention [1] - Cervical cancer is a significant health threat to women, with over 90% of HPV-related cancers being cervical cancer, leading to approximately 150,000 new cases and 55,700 deaths annually in China [1] - The vaccination will be provided to eligible girls who are Chinese nationals, starting school in Beijing in September 2025, and who have no contraindications for vaccination [1] Group 2 - The vaccine to be used is a domestically produced bivalent HPV vaccine, administered in two doses according to a 0 and 6-month immunization schedule [1] - The first dose is planned to be completed by the end of October 2025, and the second dose by the end of May 2026 [1] - All approved HPV vaccines (bivalent, quadrivalent, and nonavalent) have similar immunogenicity and efficacy in preventing cervical cancer precursors and cancer caused by HPV types 16 and 18 [2]